We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Taking Risks with Translational Research.
- Authors
Mills, Ian G.; Sykes, Richard B.
- Abstract
The recent bankruptcy fi ling by deCODE, a company with an exceptional pedigree in associating genetic variance with disease onset, highlights the commercial risks of translational research. Indeed, deCODE's approach was similar to that adapted by academic researchers who seek to connect genetics and disease. We argue here that neither a purely corporate nor purely academic model is entirely appropriate for such research. Instead, we suggest that the private sector undertake the high-throughput elements of translational research, while the public sector and governments assume the role of providing long-term funding to develop gifted scientists with the confi dence to attempt to use genetic data as a stepping stone to a truly mechanistic understanding of complex disease.
- Publication
Science Translational Medicine, 2010, Vol 2, Issue 24, p1
- ISSN
1946-6234
- Publication type
Article
- DOI
10.1126/scitranslmed.3000667